Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Revelation Biosciences Logo
Revelation Biosciences Growth Score
90
CB Rank
9869
Heat Score
66
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
Founded
obfuscation
PublicPost-IPO Equity Menlo Park, California, United States11-50 www.revbiosciences.com
Biotechnology
Health Care
Medical
Therapeutics
Overview

Revelation Biosciences
Total Funding
obfuscation
Growth Score
90
Heat Score
66

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score90
-6 pts
in past quarter
Heat Score 66
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Revelation Biosciences

CB Rank
9869
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
Founded
obfuscation
PublicPost-IPO Equity Menlo Park, California, United States11-50 www.revbiosciences.com
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • James Rolke Logo
    James Rolke: Director and Chief Executive Officer
    Past Role: La jolla Pharmaceutical, Chief Scientific Officer
  • Chester S. Zygmont, III Logo
    Chester S. Zygmont, III: Co-Founder, CFO and Director
    Past Role: La jolla Pharmaceutical, Director of Finance

Details

Legal Name Revelation Therapeutics, LLC
Also Known As Revelation Therapeutics
Operating Status Active
Stock Symbol  NASDAQ:REVB
Company Type For Profit
Founders  Chester S. Zygmont, III, George Tidmarsh
About the Company
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
Phone Number 1-650-800-3717
Contact Email info@revbiosciences.com
Predictions & Insights

Growth Insight

See this Growth Insight
Revelation Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Gemini
A proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®) for systemic administration, developed for multiple indications including prevention of post-surgical infection, acute kidney injury, and chronic kidney disease.
GEM-AKI
A potential therapy for the treatment of acute kidney injury (AKI) by redirecting the innate immune response from a pro-inflammatory state to an anti-inflammatory state.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Revelation Biosciences Logo
Post-IPO Equity - Revelation Biosciences
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 1 Contacts 12

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

650
100%
 in past month

IT Spend

$130.5KThis year, Revelation Biosciences is projected to spend $130.5K on IT, according to Aberdeen.

Active Website Tech Count

3Revelation Biosciences is actively using 3 technologies for its website, according to BuiltWith. These include Shutterstock.
Sub-Organizations
Frequently Asked Questions

Where is Revelation Biosciences's headquarters? Revelation Biosciences is located in Menlo Park, California, United States.Who invested in Revelation Biosciences? Revelation Biosciences has 2 investors including Global Health Funds and  National Securities Corporation.When was the last funding round for Revelation Biosciences? Revelation Biosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Revelation Biosciences raised to date? Revelation Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|